Evolution of acute myelogenous leukemia stem cell properties after treatment and progression

Author:

Ho Tzu-Chieh1ORCID,LaMere Mark2,Stevens Brett M.3,Ashton John M.4ORCID,Myers Jason R.4ORCID,O’Dwyer Kristen M.2,Liesveld Jane L.2ORCID,Mendler Jason H.2,Guzman Monica5,Morrissette Jennifer D.6,Zhao Jianhua6,Wang Eunice S.7,Wetzler Meir7,Jordan Craig T.3ORCID,Becker Michael W.2ORCID

Affiliation:

1. Department of Biomedical Engineering, Columbia University, New York, NY;

2. Department of Medicine, J. P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY;

3. Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO;

4. Genomics Research Center, J. P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY;

5. Department of Pharmacology in Medicine, Weill Medical College of Cornell University, New York, NY;

6. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and

7. Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY

Abstract

Key Points Using AML as a model, we investigated the effect of treatment and disease evolution on functionally defined cancer stem cell populations. We demonstrate large-scale changes in LSC frequency and phenotype after relapse, best described using high-dimensional space analyses.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3